We retrospectively analysed morbidity, mortality and oncological results of patients who had undergone surgery for bronchial carcinoid tumours.
INTRODUCTION
Bronchial carcinoids are rare neoplasms representing 2-5% of all pulmonary tumours [1] . They can be classified histopathologically as typical and atypical and associated with a low and intermediate degree of malignancy, respectively.
The treatment of choice is lung parenchymal resection in combination with or without bronchial and/or vascular reconstruction that may be required for some centrally located lesions [2, 3] . The use of an isolated bronchial sleeve without parenchymal sacrifice is indicated when the tumour has limited endobronchial development. Experiences in surgical management of pulmonary carcinoids have been reported, but no multiple large single-institution case series are available in the literature owing to the rarity of these neoplasms. Moreover, there is no clear agreement on the main prognostic factor between nodal stage and atypical presentation [2, [4] [5] [6] [7] . For these reasons, more data are needed to investigate more deeply the biological behaviour and the oncological outcome after treatment of these uncommon tumours. We retrospectively analysed morbidity, mortality and oncological results of patients who underwent pulmonary and/or bronchial sleeve resection for carcinoids at our institution.
MATERIALS AND METHODS
Between January 2002 and March 2012, 65 patients underwent surgery for bronchial carcinoid tumours. There were 28 male (43%) and 37 female (57%) patients with a mean age of 60.6 ± 15 (range 15-86) years. Sixty-three percent of patients (n = 41) were former or current smokers. The preoperative mean forced expiratory volume in 1 s (FEV1) was 99.4 ± 21.5% of predicted. Clinical and demographic characteristics of the patients are reported in Table 1 .
Preoperatively, 67.7% of patients (n = 44) were asymptomatic and 32.3% of patients (n = 21) had tumour-related symptoms (cough: 14; haemoptysis: 6 and Cushing's syndrome: 1). All patients underwent radical resection (R0) with free bronchial and vascular margins. Lobectomy was performed in 39 (60%) patients (including 4 patients with bronchial reconstruction and 1 with bronchovascular sleeve resection). Sublobar resection (segmentectomy/ wedge) was performed in 18 (27.7%) patients. Pneumonectomy was performed in 4 patients (including 1 patient with reconstruction of the carina). An isolated bronchial sleeve resection was performed in 4 (6.2%) patients. Two patients had undergone endoscopic laser and mechanical ablation for neoplastic endobronchial obstruction before surgery.
The non-invasive staging assessment included total-body computed tomography (CT) scan with contrast medium, fibreoptic bronchoscopy and bone scintigraphy. Magnetic resonance of the brain was performed only in patients presenting with contraindication for contrast medium at the CT scan. Since January 2003, preoperative fludeoxyglucose positron emission tomography (FDG-PET) was performed in cases of suspected concomitant pathological hilar and/or mediastinal lymph nodes as an alternative to mediastinoscopy.
The pulmonary functional assessment was performed by spirometry and blood gas analysis; additional functional tests such as stress tests and ventilation-perfusion lung scintigraphy were performed in high-risk patients. Cardiac evaluation was routinely performed by electrocardiography (ECG); echocardiography was performed in all patients who had an abnormal ECG or previous history of cardiac disease.
All the patients obtained preoperative histological or cytological diagnosis by CT-guided fine-needle aspiration biopsy (FNAB) for peripherally sited nodules and by endoscopic biopsies or transbronchial needle aspiration for lesions with a prevailing central development.
None of the patients included in this series presented with a mediastinal lymph node-positive clinical status or received induction therapy (chemotherapy and/or radiation therapy).
The surgical technique for sleeve resection and reconstruction of the bronchus and the pulmonary artery (PA) has been reported previously [8, 9] . In all cases of sleeve resections, the bronchial anastomosis was protected by an intercostal muscle flap [10] . The bronchial stump was covered by a vascularized omental flap harvested through the diaphragm in 2 patients undergoing pneumonectomy who were considered at high risk for bronchial fistula occurrence.
The technique for the transdiaphragmatic transposition of the greater omentum has been previously reported [11] .
A systematic lymph node dissection was performed in all surgical procedures. Operative morbidity or mortality was considered to be within 30 days postoperatively.
An intraoperative histological evaluation of the bronchial resection margins was performed on each surgical specimen.
All resected specimens were sent for histological examination, and all tumours were classified according to the World Health Organization (WHO) and International Association for the Study of Lung Cancer (IASLC) for neuroendocrine tumours (the number of mitoses ≥2 and <10 per 2 mm, with the presence of necrosis, classified the diagnosis as the atypical form) [12] .
All types of postoperative complications, including minor complications, were recorded.
The oncological follow-up was performed with a whole-body CT scan repeated every 6 months for the first 2 years and once a year thereafter for 3 years. After bronchial or carinal reconstruction, fibreoptic bronchoscopy was performed 1, 6 and 12 months postoperatively and once a year for 4 years thereafter. Octreotide scintigraphy (OctreoScan, Mallinckrodt Medical, Inc., St. Louis, MO, USA) was used in all follow-up and a Gallium-68 PET/CT scan was used in all follow-up after 2010 to locate recurrences. The median follow-up was 58 (range 2-121) months. Most patients with AC and/ or pathological nodal involvement underwent adjuvant chemotherapy after surgical treatment.
Statistical analysis
Data were collected and stored using an Excel database (Microsoft Corp., Redmond, WA, USA). Quantitative variables were expressed as mean ± SD, whereas nominal variables were expressed binarily as presence (1) or absence (0) of the event. In the univariate analysis, qualitative variables were analysed with the Pearson χ 2 test or Fisher's exact test as required. Multivariate analysis was performed on variables that showed statistical significance at univariate analysis. Univariate and multivariate analyses of risk factors for morbidity were performed by logistic regression. Univariate and multivariate analyses of disease-free survival were performed by Cox regression. Survival curves were plotted with the KaplanMeier formula; the log-rank test was performed to compare survival between different groups.
RESULTS
Histological findings were typical carcinoid (TC) in 55 (84.6%) patients and atypical carcinoid (AC) in 10 (15.4%). Pathological nodal status was N1 in 17 patients and N2 in 2. No intraoperative complications occurred. Postoperative complications occurred in 10 (15.4%) patients. The most frequent complications were prolonged air leak (n = 4) and atrial fibrillation (n = 3). Other postoperative complications included pulmonary atelectasis due to bronchial secretions (1 patient), pneumonitis (1 patient) and postoperative bleeding requiring redo thoracotomy (1 patient). No postoperative complications related to the bronchial or vascular reconstruction occurred. No patients undergoing bronchoplasty experienced postoperative complications. At univariate analysis of risk factors for morbidity, only preoperative FEV1<70% and heart disease (hypertension, history of atrial fibrillation, history of cerebrovascular disease and ischaemic heart disease) were negative prognostic factors ( Table 2 ). The multivariate analysis did not confirm these two variables as negative prognostic factors (Table 2) . No perioperative mortality was observed. All the patients with AC and pathological nodal status N1-N2 received adjuvant chemotherapy (n = 5). The recurrence rate was 12.3% (n = 8; loco-regional 2 and distant 6). Distant recurrence was hepatic in 5 patients and pancreatic in 1 (in 2 patients, histology showed a more aggressive neuroendocrine neoplasm than the resected primary tumour). Three patients with distant recurrence had been classified as Stage I TC at thoracotomy.
Overall 3-and 5-year survival rates were 100 and 97%, respectively (Fig. 1A) . Disease-free (no recurrence) 3-and 5-year survival rates were 92 and 82%, respectively (Fig. 1B) .
Overall 3-and 5-year survival rates based on histological findings were 100% at 5 years for patients with TC and 100% at 3 years and 87.5% at 5 years for patients with AC. The difference between the two groups in terms of overall survival was not statistically significant (P = 0.33) (Fig. 2) . Disease-free (no recurrence) 3-and 5-year survival rates were 95 and 93% for patients with TC, and 78 and 44% for patients with AC, respectively. The difference in terms of diseasefree survival between the two histological subtypes was statistically significant (P = 0.004), indicating a benefit for the TC group (Fig. 3) . When considering overall 3-and 5-year survival rates based on nodal status, no significant differences were reported between pathological stage N1-N2 patients and N0 patients (N0 group: 100% at 5 years versus N1-N2 group: 100% at 3 years and 93% at 5 years, P = 0.77) (Fig. 4) . Moreover, no significant differences were found between these two subsets in term of disease-free (no recurrence) 3-and 5-year survival rates (91 and 83% in the N0 group, and 94 and 81% in the N1-N2 group, respectively, P = 0.58) (Fig. 5) .
Taking into account the whole study population, a significant advantage in disease-free survival was found at univariate analysis for TC versus AC (P = 0.005) and for adjuvant chemotherapy versus no adjuvant chemotherapy (P = 0.017). No significant advantage was found at univariate analysis for the following variables: standard lung resection versus sleeve resection, sublobar resection versus major parenchymal resection. (Table 3) . At multivariate analysis, only AC confirmed as negative prognostic factors (Table 3) .
DISCUSSION
Bronchial carcinoids are rare pulmonary neoplasms characterized by a better prognosis than other primary malignancies of the lung. The WHO 2004 classification catalogues neuroendocrine tumours (NETs) also according to the grade of biological aggressiveness (G1-G3) and the extent of differentiation (well differentiated/poorly differentiated). The well-differentiated neoplasms comprise typical (G1) and atypical carcinoids (G2) [12] . This subdivision between G1 and G2 and the traditional one of typical versus atypical seems to be superposable. The more recent WHO 2010 classification of digestive neuroendocrine neoplasms based on Ki67 proliferation assessment proved to be prognostically effective. Interestingly, a recent paper comparing these two classifications for NETs showed that WHO 2004 stratified patients into three major groups with statistically significant survival difference (typical versus atypical, P = 0.021), confirming the clinical validity of the traditional classification of TC versus AC used in the present study [13] .
Only few patients included in this study had biomarkers. In addition, these patients were not equally distributed over the time; in particular, they were operated during the last study's period. For this reason, the current authors decided not to consider these data.
No patients included in the study presented preoperatively with clinically positive mediastinal lymph node status or needed induction chemotherapy, which suggested the low malignant potential that is associated with bronchial carcinoid tumours as reported by others [14] .
Bronchoscopy is a key approach for diagnostic purposes and airway patency restoration in symptomatic cases [15] [16] [17] [18] .
Surgical resection combined with lymphadenectomy is the best therapeutic approach [15, 19] . Literature studies in this setting have reported clear evidence that radical exeresis is the most effective therapeutic option for the treatment of bronchial carcinoid [20] . The standard treatment for TC is complete resection by both anatomical and wedge resection with mediastinal lymph node sampling, while lobectomy with mediastinal lymph node dissection is preferable in cases of suspected AC [21] .
In this regard, the approach always used in the present study was to perform a major resection, with or without bronchial reconstruction, in order to avoid pneumonectomy whenever possible, except in patients with compromised functional status that contraindicated a lobectomy. When the tumour had an exclusive endobronchial growth and its radical resection was possible, we performed a bronchoplasty without parenchymal sacrifice. In addition, the choice of the surgical intervention (type and extent of lung resection or preference for bronchial reconstructive lung sparing operations) was based on the location of the tumour (central or peripheral), the degree of parenchymal and/or bronchial involvement and on the cardiorespiratory reserve of each patient. Surgical resection of peripheral carcinoids was performed by lobectomy or sublobar resection (segmentectomy or wedge). The excision of centrally located tumours with involvement of the main bronchus and the origin of a lobar bronchus and/or PA branches was performed by sleeve resection or pneumonectomy. That management demonstrated excellent results in terms of perioperative morbidity and mortality.
The high rates of long-term overall and disease-free survival observed in the present study confirmed the low malignancy potential of such neuroendocrine pulmonary tumours.
Currently, nodal stage and atypical presentation have been reported as the most significant prognostic factors in main case series of patients surgically treated for bronchial carcinoids [2, 3, 5, 17]. Better prognostication and understanding of the factors influencing the oncological outcome after treatment of these uncommon tumours will require deeper investigations. The present study focused on those two prognostic factors in order to assess their impact on the oncological results of patients who had undergone pulmonary resection and/or bronchial sleeve resection for carcinoid at our institution. The present study did not show a statistically significant difference between the two groups (N0 versus N+) in the stratification of the patients based on the presence of pathological lymph node involvement ( pN1-N2) in terms of overall and disease-free survival. That result suggested that pathological nodal status had a lower impact on survival of patients with bronchial carcinoid when compared with patients with lung cancer [17] .
The evidence in the present study differed from literature reports, but it may have resulted from the small size of the statistical sample [22] . In particular, Cardillo et al. [17] reported that prognosis in bronchial carcinoid tumours is more influenced by nodal status than by histological subtype. However, our analysis of disease-free survival based on histology (AC versus TC) showed a statistically significant difference in favour of the group of patients with TC. This result confirmed, as already observed in other published series [2, 23] , that the atypical subtype had a higher propensity for the development of local recurrence and distant recurrence in particular. Our series' data showed that only histological subtype (and not nodal status) can influence disease-free survival with a statistically significant advantage for TC (P = 0.004).
A recent multicentre study demonstrated that patients who had atypical bronchial carcinoid tumours experienced a significantly higher recurrence rate than those with a typical histological profile; furthermore, nodal involvement increased the risk of recurrence in both histological subtypes [24] .
All the patients included in the present study underwent radical resection of the tumour with systematic hilar and mediastinal lymph node dissection, even when video-assisted surgery was conducted. The distribution of different types of surgical resection was similar between patients with or without pathological nodal involvement and between patients with TC or AC. For that reason, the surgical approach was not considered a significant prognostic factor preliminarily. Moreover, data from the univariate analysis for disease-free survival showed that recurrence was not influenced by the type of intervention performed. No significant differences were found when comparing sublobar resection with major resection and when comparing bronchial reconstructive procedures (n = 9) with standard parenchymal operations. That result indicated that the radical nature of treatment was not jeopardized when sleeve resection was performed for bronchial carcinoid. The data were also remarkable in that they suggested that complex lung sparing operations might offer the same oncological results as other standard lung resections for the treatment of bronchial carcinoid. Nevertheless, much more data and a larger patient cohort would be necessary to validate that observation.
Although bronchovascular reconstructions associated with lobectomy represent surgical procedures with a higher technical complexity when compared with standard major lung resections, postoperative morbidity and mortality data from a number of studies published after 2005 reported overall better results for patients undergoing sleeve resection with respect to pneumonectomy for non-small-cell lung cancer [25] . 
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To the best of our knowledge, however, no published large experience is actually available in the literature comparing longterm results of sleeve lobectomy with those of standard major lung resections performed for bronchial carcinoid tumour.
Most patients with atypical histological subtype and/or pathological nodal involvement including in the current series underwent adjuvant chemotherapy after surgical treatment.
Interestingly, although AC showed a significantly higher recurrence rate than TC, these data did not significantly affect the overall survival rates. That may be because 8-to 10-year survival is well documented in patients treated for bronchial carcinoid tumour metastases [21, 23] .
In one third of patients in the present study with distant recurrence (those with a worse prognosis), histology evolved towards a more aggressive pattern of neuroendocrine neoplasm than resected primary tumours.
We conclude that surgical treatment of bronchial carcinoid provided high long-term survival rates if a radical resection was performed. Low postoperative morbidity and mortality can be expected even if complex interventions such as bronchial reconstruction are performed. This single-institution experience also confirmed that typical bronchial carcinoids have a low degree of malignancy, but have a more aggressive attitude in atypical forms. In particular, the AC appeared to be the main factor in determining the risk of recurrence. Bronchial reconstructive lung sparing operations were not related to an increased recurrence rate. Moreover, the study suggested that a long-term postoperative surveillance of patients would be warranted since the occurrence of long-term relapses is not unusual. 
